[Effect of Tpo and/or IL-11 gene modified stromal cells on the expansion of CD34+ CD38- hematopoietic primitive progenitor cells]. 2003

Ling-ling Lu, and Guang Yang, and Liang Li, and Xue-tao Pei, and Ya-de Zhou, and Kai Feng, and Ci-xian Bai
Chongqing Children's Hospital, Chongqing 400014, China.

OBJECTIVE To investigate the effects of Tpo and/or IL-11 gene modified stromal cells on the expansion of CD(34)(+) hematopoietic stem/progenitor cells in cord blood. METHODS Retroviral vectors containing Tpo or IL-11 gene were constructed and used to transfect the stromal cell line HFCL. Tpo and/or IL-11 mRNA was assayed by Northern blot. Non-modified stromal cells were used, CD(34)(+) hematopoietic stem/progenitor cells from cord blood were expanded on gene-modified stromal cells for 7 days. The phenotype of CD(34)(+)CD(38)(-) primitive progenitors was detected by flow cytometry. RESULTS HFCL expressed Tpo and/or IL-11 mRNA after transfected by the retroviral vectors. The percentages of CD(34)(+)CD(38)(-) primitive progenitors in the cultures of Tpo, IL-11 and Tpo + IL-11 modified HFCL were (1.8 +/- 0.24)%, (1.62 +/- 0.23)%, and (2.45 +/- 0.28)%, respectively, which were higher than that in the control [(0.8 +/- 0.23)%]. CONCLUSIONS The stromal cells modified by Tpo and/or IL-11 gene were able to enhance ex vivo expansion of CD(34)(+) and CD(34)(+)CD(38)(-) hematopoietic stem/progenitor cells from cord blood.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D005312 Fetal Blood Blood of the fetus. Exchange of nutrients and waste between the fetal and maternal blood occurs via the PLACENTA. The cord blood is blood contained in the umbilical vessels (UMBILICAL CORD) at the time of delivery. Cord Blood,Umbilical Cord Blood,Blood, Cord,Blood, Fetal,Blood, Umbilical Cord,Bloods, Cord,Bloods, Fetal,Bloods, Umbilical Cord,Cord Blood, Umbilical,Cord Bloods,Cord Bloods, Umbilical,Fetal Bloods,Umbilical Cord Bloods
D006412 Hematopoietic Stem Cells Progenitor cells from which all blood cells derived. They are found primarily in the bone marrow and also in small numbers in the peripheral blood. Colony-Forming Units, Hematopoietic,Progenitor Cells, Hematopoietic,Stem Cells, Hematopoietic,Hematopoietic Progenitor Cells,Cell, Hematopoietic Progenitor,Cell, Hematopoietic Stem,Cells, Hematopoietic Progenitor,Cells, Hematopoietic Stem,Colony Forming Units, Hematopoietic,Colony-Forming Unit, Hematopoietic,Hematopoietic Colony-Forming Unit,Hematopoietic Colony-Forming Units,Hematopoietic Progenitor Cell,Hematopoietic Stem Cell,Progenitor Cell, Hematopoietic,Stem Cell, Hematopoietic,Unit, Hematopoietic Colony-Forming,Units, Hematopoietic Colony-Forming
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013926 Thrombopoietin A humoral factor that stimulates the production of thrombocytes (BLOOD PLATELETS). Thrombopoietin stimulates the proliferation of bone marrow MEGAKARYOCYTES and their release of blood platelets. The process is called THROMBOPOIESIS. Megakaryocyte Growth and Development Factor,c-mpl Ligand,MGDF Factor,Megakaryocyte Colony Stimulating Factor,Myeloproliferative Leukemia Virus Oncogene Ligand,Thrombocytopoiesis-Stimulating Factor,Thrombocytopoietin,mpl Ligand,Ligand, c-mpl,Ligand, mpl,Thrombocytopoiesis Stimulating Factor
D015703 Antigens, CD Differentiation antigens residing on mammalian leukocytes. CD stands for cluster of differentiation, which refers to groups of monoclonal antibodies that show similar reactivity with certain subpopulations of antigens of a particular lineage or differentiation stage. The subpopulations of antigens are also known by the same CD designation. CD Antigen,Cluster of Differentiation Antigen,Cluster of Differentiation Marker,Differentiation Antigens, Leukocyte, Human,Leukocyte Differentiation Antigens, Human,Cluster of Differentiation Antigens,Cluster of Differentiation Markers,Antigen Cluster, Differentiation,Antigen, CD,CD Antigens,Differentiation Antigen Cluster,Differentiation Marker Cluster,Marker Cluster, Differentiation
D017154 Stromal Cells Connective tissue cells of an organ found in the loose connective tissue. These are most often associated with the uterine mucosa and the ovary as well as the hematopoietic system and elsewhere. Cell, Stromal,Cells, Stromal,Stromal Cell
D017370 Interleukin-11 A lymphohematopoietic cytokine that plays a role in regulating the proliferation of ERYTHROID PRECURSOR CELLS. It induces maturation of MEGAKARYOCYTES which results in increased production of BLOOD PLATELETS. Interleukin-11 was also initially described as an inhibitor of ADIPOGENESIS of cultured preadipocytes. Adipogenesis Inhibitory Factor,IL-11,IL11,Factor, Adipogenesis Inhibitory,Inhibitory Factor, Adipogenesis,Interleukin 11
D051997 ADP-ribosyl Cyclase 1 A bifunctional enzyme that catalyzes the synthesis and HYDROLYSIS of CYCLIC ADP-RIBOSE (cADPR) from NAD+ to ADP-RIBOSE. It is a cell surface molecule which is predominantly expressed on LYMPHOID CELLS and MYELOID CELLS. Antigens, CD38,CD38 Antigens,ADPR Cyclase CD38,ADPR Cyclase T10,Acute Lymphoblastic Leukemia Cells Antigen CD38,CD38 Antigen,Lymphocyte Differentiation Antigen CD38,NIM-R5 Antigen,T10 Antigen,1, ADP-ribosyl Cyclase,ADP ribosyl Cyclase 1,Antigen, T10,CD38, ADPR Cyclase,Cyclase 1, ADP-ribosyl,Cyclase CD38, ADPR,Cyclase T10, ADPR,NIM R5 Antigen

Related Publications

Ling-ling Lu, and Guang Yang, and Liang Li, and Xue-tao Pei, and Ya-de Zhou, and Kai Feng, and Ci-xian Bai
September 1994, The Journal of experimental medicine,
Ling-ling Lu, and Guang Yang, and Liang Li, and Xue-tao Pei, and Ya-de Zhou, and Kai Feng, and Ci-xian Bai
August 1995, Experimental hematology,
Ling-ling Lu, and Guang Yang, and Liang Li, and Xue-tao Pei, and Ya-de Zhou, and Kai Feng, and Ci-xian Bai
November 1995, Blood,
Ling-ling Lu, and Guang Yang, and Liang Li, and Xue-tao Pei, and Ya-de Zhou, and Kai Feng, and Ci-xian Bai
September 1996, Blood,
Ling-ling Lu, and Guang Yang, and Liang Li, and Xue-tao Pei, and Ya-de Zhou, and Kai Feng, and Ci-xian Bai
October 2001, Science in China. Series C, Life sciences,
Ling-ling Lu, and Guang Yang, and Liang Li, and Xue-tao Pei, and Ya-de Zhou, and Kai Feng, and Ci-xian Bai
September 1997, Gene therapy,
Ling-ling Lu, and Guang Yang, and Liang Li, and Xue-tao Pei, and Ya-de Zhou, and Kai Feng, and Ci-xian Bai
June 1997, Transplantation proceedings,
Ling-ling Lu, and Guang Yang, and Liang Li, and Xue-tao Pei, and Ya-de Zhou, and Kai Feng, and Ci-xian Bai
November 1998, Biotechnology and bioengineering,
Ling-ling Lu, and Guang Yang, and Liang Li, and Xue-tao Pei, and Ya-de Zhou, and Kai Feng, and Ci-xian Bai
February 2002, Experimental hematology,
Ling-ling Lu, and Guang Yang, and Liang Li, and Xue-tao Pei, and Ya-de Zhou, and Kai Feng, and Ci-xian Bai
June 1996, The Journal of experimental medicine,
Copied contents to your clipboard!